Glucagon-like peptide-1 receptor agonists reduce major adverse cardiovascular events and worsening heart failure in patients with heart failure: an umbrella meta-analysis
Sun C, Meng C, Yuan Y, et al.
BMC Endocr Disord. Pub. online 2 Apr 2026.
Leggi


